Apogee Therapeutics, Inc. (APGE)
Form 4 sales, Form 144 notices and lockup dates Biological Products, (No Diagnostic Substances), in Life sciences.
- Latest sale
- $738k
- Aug 5 · Routine
- Form 4 sales
- 62
- On record
- Form 144 notices
- 34
- Proposed sales
- Sold, last 30 days
- None
- No Form 4 sale
- Sold, last 90 days
- None
- No Form 4 sale
- Next unlock
- None
- No lockup ahead
Lockups
- LockupFrom the 424B4Jun 5, 2024 900 days ago
90 days from Mar 7, 2024.
- IPO lockupAssumed dateJan 9, 2024 1048 days ago
180 days after the closing. The prospectus also states 90 days.
Sales by reason
Timeline
- Aug 5, 2026Routine
Dambkowski Carl, Chief Medical Officer, sold 3.2% of their holdings
$738k5,500 shares at $134.17
- Jul 8, 2026Routine
Henderson Michael Thomas, Chief Executive Officer, sold 2% of their holdings
$2.7M20,000 shares at $133.63
- Jul 1, 2026Routine
Dambkowski Carl, Chief Medical Officer, sold 3% of their holdings
$730k5,500 shares at $132.74
- Jul 1, 2026Notice
Dambkowski Carl, Chief Medical Officer, filed a notice to sell 16,500 shares
$2.2M16,500 shares
- Jun 22, 2026Unusual
Dambkowski Carl, Chief Medical Officer, sold 12.8% of their holdings
$3.5M26,400 shares at $132.60
- Jun 22, 2026Unusual
Henderson Michael Thomas, Chief Executive Officer, sold 7.3% of their holdings
$10.6M80,000 shares at $132.54
- Jun 22, 2026Notice
Dambkowski Carl, Chief Medical Officer, filed a notice to sell 15,400 shares
$1.4M15,400 shares
- Jun 22, 2026Notice
Henderson Michael Thomas, Chief Executive Officer, filed a notice to sell 80,000 shares
$10.6M80,000 shares
- Jun 10, 2026Routine
Henderson Michael Thomas, Chief Executive Officer, sold 1.8% of their holdings
$1.7M20,000 shares at $83.38
- Jun 3, 2026Routine
Dambkowski Carl, Chief Medical Officer, sold 2.6% of their holdings
$433k5,500 shares at $78.71
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Sep 3, 2026 | APGE | McKenna Mark C. | Director | Returned to the companyStock Option (Right to Buy) | 182,488 | 0 | SEC | ||
| Sep 3, 2026 | Sep 3, 2026 | APGE | McKenna Mark C. | Director | Returned to the company | 20,000 | 0 | SEC | ||
| Sep 3, 2026 | Sep 3, 2026 | APGE | Jones William A Jr | Director | Returned to the companyStock Option (Right to Buy) | 32,488 | 0 | SEC | ||
| Sep 3, 2026 | Sep 3, 2026 | APGE | Jones William A Jr | Director | Returned to the company | 34,824 | 0 | SEC | ||
| Sep 3, 2026 | Sep 3, 2026 | APGE | Dambkowski Carl | Chief Medical Officer | Returned to the companyStock Option (Right to Buy) | 319,317 | 0 | SEC | ||
| Sep 3, 2026 | Sep 3, 2026 | APGE | Dambkowski Carl | Chief Medical Officer | Returned to the company | 168,498 | $1.10 | $186k | 0 | SEC |
| Sep 3, 2026 | Sep 3, 2026 | APGE | Fox Jennifer A. | Director | Returned to the companyStock Option (Right to Buy) | 32,488 | 0 | SEC | ||
| Sep 3, 2026 | Sep 3, 2026 | APGE | Fox Jennifer A. | Director | Returned to the company | 34,824 | 0 | SEC | ||
| Sep 3, 2026 | Sep 3, 2026 | APGE | Henderson Jane | Chief Financial Officer | Returned to the companyStock Option (Right to Buy) | 383,997 | 0 | SEC | ||
| Sep 3, 2026 | Sep 3, 2026 | APGE | Henderson Jane | Chief Financial Officer | Returned to the company | 158,371 | 0 | SEC | ||
| Sep 3, 2026 | Sep 3, 2026 | APGE | Bollinger Lisa | Director | Returned to the companyStock Option (Right to Buy) | 48,780 | 0 | SEC | ||
| Sep 3, 2026 | Sep 3, 2026 | APGE | Henderson Michael Thomas | Chief Executive Officer | Returned to the companyStock Option (Right to Buy) | 997,064 | 0 | SEC | ||
| Sep 3, 2026 | Sep 3, 2026 | APGE | Henderson Michael Thomas | Chief Executive Officer | Returned to the company | 920,941 | 0 | SEC | ||
| Sep 3, 2026 | Sep 3, 2026 | APGE | Shah Nimish P | Director | Returned to the companyNon-Voting Common Stock | 7.2M | $126.73 | $911M | 0 | SEC |
| Sep 3, 2026 | Sep 3, 2026 | APGE | Shah Nimish P | Director | Returned to the company | 1.8M | $135.11 | $236M | 0 | SEC |
| Sep 3, 2026 | Sep 3, 2026 | APGE | Fairmount Funds Management LLC | Director | Returned to the companyNon-Voting Common Stock | 6.8M | 0 | SEC | ||
| Sep 3, 2026 | Sep 3, 2026 | APGE | Fairmount Funds Management LLC | Director | Returned to the company | 443,187 | 0 | SEC | ||
| Aug 7, 2026 | Aug 11, 2026 | APGE | Fairmount Healthcare Fund II L.P. | Director | Exercised or settledStock Option (Right to Buy) | 42,208 | 0 | SEC | ||
| Aug 7, 2026 | Aug 11, 2026 | APGE | Fairmount Healthcare Fund II L.P. | Director | Exercised options | 42,208 | $23.60 | $996k | 340,855 | SEC |
| Aug 5, 2026 | Aug 7, 2026 | APGE | Dambkowski Carl | Chief Medical Officer | Sold | 5,500 | $134.17 | $738k | 168,498 | SEC |
| Aug 5, 2026 | Aug 7, 2026 | APGE | Dambkowski Carl | Chief Medical Officer | Exercised or settledStock Option (Right to Buy) | 4,125 | 110,665 | SEC | ||
| Aug 5, 2026 | Aug 7, 2026 | APGE | Dambkowski Carl | Chief Medical Officer | Exercised options | 4,125 | $22.86 | $94k | 173,998 | SEC |
| Jul 24, 2026 | Jul 24, 2026 | APGE | Henderson Jane | Chief Financial Officer | Gift | 15,000 | 158,371 | SEC | ||
| Jul 14, 2026 | Jul 16, 2026 | APGE | Dambkowski Carl | Chief Medical Officer | Gift | 8,000 | 169,873 | SEC | ||
| Jul 10, 2026 | Jul 10, 2026 | APGE | Henderson Michael Thomas | Chief Executive Officer | Gift | 75,046 | 920,941 | SEC | ||
| Jul 8, 2026 | Jul 10, 2026 | APGE | Henderson Michael Thomas | Chief Executive Officer | Sold | 20,000 | $133.63 | $2.7M | 995,987 | SEC |
| Jul 1, 2026 | Jul 2, 2026 | APGE | Dambkowski Carl | Chief Medical Officer | Sold | 5,500 | $132.74 | $730k | 177,873 | SEC |
| Jul 1, 2026 | Jul 2, 2026 | APGE | Dambkowski Carl | Chief Medical Officer | Exercised or settledStock Option (Right to Buy) | 4,125 | 114,790 | SEC | ||
| Jul 1, 2026 | Jul 2, 2026 | APGE | Dambkowski Carl | Chief Medical Officer | Exercised options | 4,125 | $22.86 | $94k | 183,373 | SEC |
| Jun 22, 2026 | Jun 24, 2026 | APGE | Dambkowski Carl | Chief Medical Officer | Sold | 26,400 | $132.60 | $3.5M | 179,248 | SEC |
| Jun 22, 2026 | Jun 24, 2026 | APGE | Henderson Michael Thomas | Chief Executive Officer | Sold | 80,000 | $132.54 | $10.6M | 1M | SEC |
| Jun 10, 2026 | Jun 12, 2026 | APGE | Henderson Michael Thomas | Chief Executive Officer | Sold | 20,000 | $83.38 | $1.7M | 1.1M | SEC |
| Jun 9, 2026 | Jun 11, 2026 | APGE | Kiselak Tomas | Director | AwardedStock Option (Right to Buy) | 7,657 | 7,657 | SEC | ||
| Jun 9, 2026 | Jun 11, 2026 | APGE | Shah Nimish P | Director | AwardedStock Option (Right to Buy) | 7,657 | 7,657 | SEC | ||
| Jun 9, 2026 | Jun 11, 2026 | APGE | McKenna Mark C. | Director | AwardedStock Option (Right to Buy) | 7,657 | 7,657 | SEC | ||
| Jun 9, 2026 | Jun 11, 2026 | APGE | Jones William A Jr | Director | AwardedStock Option (Right to Buy) | 7,657 | 7,657 | SEC | ||
| Jun 9, 2026 | Jun 11, 2026 | APGE | Fox Jennifer A. | Director | AwardedStock Option (Right to Buy) | 7,657 | 7,657 | SEC | ||
| Jun 9, 2026 | Jun 11, 2026 | APGE | Bollinger Lisa | Director | AwardedStock Option (Right to Buy) | 7,657 | 7,657 | SEC | ||
| Jun 3, 2026 | Jun 5, 2026 | APGE | Dambkowski Carl | Chief Medical Officer | Sold | 5,500 | $78.71 | $433k | 205,648 | SEC |
| Jun 3, 2026 | Jun 5, 2026 | APGE | Dambkowski Carl | Chief Medical Officer | Exercised or settledStock Option (Right to Buy) | 4,125 | 118,915 | SEC | ||
| Jun 3, 2026 | Jun 5, 2026 | APGE | Dambkowski Carl | Chief Medical Officer | Exercised options | 4,125 | $22.86 | $94k | 211,148 | SEC |
| May 13, 2026 | May 15, 2026 | APGE | Henderson Michael Thomas | Chief Executive Officer | Sold | 20,000 | $82.09 | $1.6M | 1.1M | SEC |
| May 6, 2026 | May 8, 2026 | APGE | Dambkowski Carl | Chief Medical Officer | Sold | 5,500 | $84.14 | $463k | 207,023 | SEC |
| May 6, 2026 | May 8, 2026 | APGE | Dambkowski Carl | Chief Medical Officer | Exercised or settledStock Option (Right to Buy) | 4,125 | 123,040 | SEC | ||
| May 6, 2026 | May 8, 2026 | APGE | Dambkowski Carl | Chief Medical Officer | Exercised options | 4,125 | $22.86 | $94k | 212,523 | SEC |
| May 1, 2026 | May 4, 2026 | APGE | Henderson Jane | Chief Financial Officer | Sold | 2,000 | $82.04 | $164k | 173,371 | SEC |
| Apr 16, 2026 | Apr 20, 2026 | APGE | Henderson Michael Thomas | Chief Executive Officer | Exercised or settledStock Option (Right to Buy) | 3,000 | 387,012 | SEC | ||
| Apr 16, 2026 | Apr 20, 2026 | APGE | Henderson Michael Thomas | Chief Executive Officer | Exercised options | 3,000 | $22.86 | $69k | 1.1M | SEC |
| Apr 16, 2026 | Apr 17, 2026 | APGE | Henderson Jane | Chief Financial Officer | Sold | 2,000 | $90.00 | $180k | 175,371 | SEC |
| Apr 8, 2026 | Apr 10, 2026 | APGE | Henderson Michael Thomas | Chief Executive Officer | Sold | 20,000 | $82.58 | $1.7M | 1.1M | SEC |
Sales, notices and lockups (99)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Aug 7, 2026 | Dambkowski Carl | APGE | Chief Medical Officer | Form 4 sale | 5,500 | $738k | 3.2% | Routine | SEC |
| Jul 8, 2026 | Jul 10, 2026 | Henderson Michael Thomas | APGE | Chief Executive Officer | Form 4 sale | 20,000 | $2.7M | 2.0% | Routine | SEC |
| Jul 1, 2026 | Jul 2, 2026 | Dambkowski Carl | APGE | Chief Medical Officer | Form 4 sale | 5,500 | $730k | 3.0% | Routine | SEC |
| Jul 1, 2026 | Jul 1, 2026 | Dambkowski Carl | APGE | Chief Medical Officer | Form 144 notice | 16,500 | $2.2M | Notice | SEC | |
| Jun 22, 2026 | Jun 24, 2026 | Dambkowski Carl | APGE | Chief Medical Officer | Form 4 sale | 26,400 | $3.5M | 12.8% | Unusual | SEC |
| Jun 22, 2026 | Jun 24, 2026 | Henderson Michael Thomas | APGE | Chief Executive Officer | Form 4 sale | 80,000 | $10.6M | 7.3% | Unusual | SEC |
| Jun 22, 2026 | Jun 22, 2026 | Dambkowski Carl | APGE | Chief Medical Officer | Form 144 notice | 15,400 | $1.4M | Notice | SEC | |
| Jun 22, 2026 | Jun 22, 2026 | Henderson Michael Thomas | APGE | Chief Executive Officer | Form 144 notice | 80,000 | $10.6M | Notice | SEC | |
| Jun 10, 2026 | Jun 12, 2026 | Henderson Michael Thomas | APGE | Chief Executive Officer | Form 4 sale | 20,000 | $1.7M | 1.8% | Routine | SEC |
| Jun 3, 2026 | Jun 5, 2026 | Dambkowski Carl | APGE | Chief Medical Officer | Form 4 sale | 5,500 | $433k | 2.6% | Routine | SEC |
| May 13, 2026 | May 15, 2026 | Henderson Michael Thomas | APGE | Chief Executive Officer | Form 4 sale | 20,000 | $1.6M | 1.8% | Routine | SEC |
| May 13, 2026 | May 13, 2026 | Henderson Michael Thomas | APGE | Chief Executive Officer | Form 144 notice | 60,000 | $4.9M | Notice | SEC | |
| May 6, 2026 | May 8, 2026 | Dambkowski Carl | APGE | Chief Medical Officer | Form 4 sale | 5,500 | $463k | 2.6% | Routine | SEC |
| May 6, 2026 | May 6, 2026 | Dambkowski Carl | APGE | Chief Medical Officer | Form 144 notice | 22,000 | $1.8M | Notice | SEC | |
| May 1, 2026 | May 4, 2026 | Henderson Jane | APGE | Chief Financial Officer | Form 4 sale | 2,000 | $164k | 1.1% | Routine | SEC |
| May 1, 2026 | May 1, 2026 | Henderson Jane | APGE | Chief Financial Officer | Form 144 notice | 2,000 | $166k | Notice | SEC | |
| Apr 16, 2026 | Apr 17, 2026 | Henderson Jane | APGE | Chief Financial Officer | Form 4 sale | 2,000 | $180k | 1.1% | Routine | SEC |
| Apr 8, 2026 | Apr 10, 2026 | Henderson Michael Thomas | APGE | Chief Executive Officer | Form 4 sale | 20,000 | $1.7M | 1.7% | Routine | SEC |
| Apr 1, 2026 | Apr 3, 2026 | Dambkowski Carl | APGE | Chief Medical Officer | Form 4 sale | 5,500 | $467k | 2.6% | Routine | SEC |
| Apr 1, 2026 | Apr 3, 2026 | Henderson Jane | APGE | Chief Financial Officer | Form 4 sale | 2,000 | $170k | 1.1% | Routine | SEC |
| Mar 25, 2026 | Mar 27, 2026 | Henderson Jane | APGE | Chief Financial Officer | Form 4 sale | 2,000 | $170k | 1.1% | Routine | SEC |
| Mar 25, 2026 | Mar 25, 2026 | Henderson Jane | APGE | Chief Financial Officer | Form 144 notice | 6,000 | $438k | Notice | SEC | |
| Mar 11, 2026 | Mar 13, 2026 | Henderson Michael Thomas | APGE | Chief Executive Officer | Form 4 sale | 20,000 | $1.5M | 1.7% | Routine | SEC |
| Mar 4, 2026 | Mar 6, 2026 | Dambkowski Carl | APGE | Chief Medical Officer | Form 4 sale | 5,500 | $391k | 2.6% | Routine | SEC |
| Mar 2, 2026 | Mar 4, 2026 | Henderson Jane | APGE | Chief Financial Officer | Form 4 sale | 2,000 | $140k | 1.1% | Routine | SEC |
| Feb 11, 2026 | Feb 13, 2026 | Henderson Michael Thomas | APGE | Chief Executive Officer | Form 4 sale | 20,000 | $1.3M | 1.7% | Routine | SEC |
| Feb 11, 2026 | Feb 11, 2026 | Henderson Michael Thomas | APGE | Chief Executive Officer | Form 144 notice | 60,000 | $3.8M | Notice | SEC | |
| Feb 4, 2026 | Feb 4, 2026 | Dambkowski Carl | APGE | Chief Medical Officer | Form 4 sale | 5,500 | $362k | 2.5% | Routine | SEC |
| Feb 2, 2026 | Feb 4, 2026 | Henderson Jane | APGE | Chief Financial Officer | Form 4 sale | 2,000 | $132k | 1.1% | Routine | SEC |
| Jan 22, 2026 | Jan 22, 2026 | Fairmount Funds Management LLC | APGE | Director | Form 144 notice | 1.8M | $134M | Notice | SEC | |
| Jan 22, 2026 | Jan 22, 2026 | Harwin Peter Evan | APGE | Director | Form 4 sale | 1.8M | $134M | 85.4% | Unusual | SEC |
| Jan 14, 2026 | Jan 16, 2026 | Henderson Michael Thomas | APGE | Chief Executive Officer | Form 4 sale | 20,000 | $1.6M | 1.6% | Routine | SEC |
| Jan 7, 2026 | Jan 9, 2026 | Dambkowski Carl | APGE | Chief Medical Officer | Form 4 sale | 18,700 | $1.5M | 8.1% | Unusual | SEC |
| Jan 7, 2026 | Jan 7, 2026 | Dambkowski Carl | APGE | Chief Medical Officer | Form 144 notice | 35,200 | $2.8M | Notice | SEC | |
| Jan 6, 2026 | Jan 6, 2026 | Henderson Jane | APGE | Chief Financial Officer | Form 4 sale | 8,000 | $609k | 4.1% | Unusual | SEC |
| Jan 2, 2026 | Jan 2, 2026 | Henderson Jane | APGE | Chief Financial Officer | Form 144 notice | 12,000 | $906k | Notice | SEC | |
| Dec 19, 2025 | Dec 23, 2025 | Henderson Jane | APGE | Chief Financial Officer | Form 4 sale | 1,500 | $120k | 0.8% | Routine | SEC |
| Dec 19, 2025 | Dec 19, 2025 | Henderson Jane | APGE | Chief Financial Officer | Form 144 notice | 1,500 | $116k | Notice | SEC | |
| Dec 10, 2025 | Dec 12, 2025 | Henderson Michael Thomas | APGE | Chief Executive Officer | Form 4 sale | 20,000 | $1.5M | 1.6% | Routine | SEC |
| Dec 4, 2025 | Dec 5, 2025 | Dambkowski Carl | APGE | Chief Medical Officer | Form 4 sale | 10,900 | $818k | 3.9% | Routine | SEC |
| Dec 4, 2025 | Dec 5, 2025 | Henderson Jane | APGE | Chief Financial Officer | Form 4 sale | 1,500 | $113k | 0.8% | Routine | SEC |
| Dec 4, 2025 | Dec 5, 2025 | Henderson Michael Thomas | APGE | Chief Executive Officer | Form 4 sale | 40,000 | $3M | 3.1% | Routine | SEC |
| Dec 4, 2025 | Dec 4, 2025 | Henderson Jane | APGE | Chief Financial Officer | Form 144 notice | 1,500 | $112k | Notice | SEC | |
| Dec 4, 2025 | Dec 4, 2025 | Dambkowski Carl | APGE | Chief Medical Officer | Form 144 notice | 10,900 | $813k | Notice | SEC | |
| Nov 25, 2025 | Nov 28, 2025 | Henderson Jane | APGE | Chief Financial Officer | Form 4 sale | 1,500 | $105k | 0.8% | Routine | SEC |
| Nov 25, 2025 | Nov 25, 2025 | Henderson Jane | APGE | Chief Financial Officer | Form 144 notice | 1,500 | $102k | Notice | SEC | |
| Nov 14, 2025 | Nov 14, 2025 | Henderson Jane | APGE | Chief Financial Officer | Form 144 notice | 2,000 | $126k | Notice | SEC | |
| Nov 14, 2025 | Nov 14, 2025 | Henderson Jane | APGE | Chief Financial Officer | Form 4 sale | 2,000 | $130k | 1.0% | Routine | SEC |
| Nov 13, 2025 | Nov 13, 2025 | Henderson Michael Thomas | APGE | Chief Executive Officer | Form 4 sale | 20,000 | $1.3M | 1.5% | Routine | SEC |
| Nov 13, 2025 | Nov 13, 2025 | Henderson Michael Thomas | APGE | Chief Executive Officer | Form 144 notice | 100,000 | $6.7M | Notice | SEC |